As CSF AD biomarkers reflect AD pathology in the brain, we assessed the correlation between the levels of CSF AD biomarkers (Aβ42, Tau, pTau), the Tau/Aβ42 ratio (TAR) and the critical proteins we identified. The gene discussed is MAPT; the disease is Alzheimer disease.